Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 HKD | +0.73% | +3.37% | -20.46% |
Jun. 25 | Sino Biopharmaceutical Gets NMPA's Nod for Marketing Diabetes Drug | MT |
Jun. 25 | Sino Biopharmaceutical Limited Receives Approval for Marketing of Liraglutide Injection | CI |
Business Summary
- chemical medicine products and biopharmaceutical drugs (97.6%);
- other (2.4%).
Number of employees: 25,806
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Modernised Chinese Medicines and Chemical Medicines
98.4
%
| 32,830 | 98.1 % | 28,477 | 98.4 % | -13.26% |
Others
1.6
%
| 638 | 1.9 % | 473 | 1.6 % | -25.87% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 33,468 | 100.0 % | 28,950 | 100.0 % | -13.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
S Y Tse
CEO | Chief Executive Officer | 28 | 19-10-22 |
Ping Tse
FOU | Founder | 72 | 00-02-01 |
Chun Ling Li
DFI | Director of Finance/CFO | 53 | - |
Hsin Tse
BRD | Director/Board Member | 54 | 95-07-31 |
Sean Chen
PRN | Corporate Officer/Principal | 46 | 21-12-31 |
Qian Li
PRN | Corporate Officer/Principal | - | 09-05-31 |
Philip Duong
PRN | Corporate Officer/Principal | 34 | 19-12-31 |
Benjamin Toogood
PRN | Corporate Officer/Principal | 48 | 20-12-31 |
Oi Nin Chan
SEC | Corporate Secretary | 56 | 15-08-24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ping Tse
FOU | Founder | 72 | 00-02-01 |
Founder | 60 | 00-02-01 | |
Hsin Tse
BRD | Director/Board Member | 54 | 95-07-31 |
Zheng Fei Lu
BRD | Director/Board Member | 61 | 05-10-31 |
Da Kui Li
BRD | Director/Board Member | 80 | 04-08-31 |
Lu Fu Zhang
BRD | Director/Board Member | 66 | 15-04-19 |
Hong Lu
BRD | Director/Board Member | 54 | 15-04-19 |
Theresa Tse
CHM | Chairman | 32 | 15-06-29 |
Kwok Tung Li
BRD | Director/Board Member | 69 | 20-12-30 |
S Y Tse
CEO | Chief Executive Officer | 28 | 19-10-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,245,310,273 | 9,731,206,595 ( 50.56 %) | 454,093,043 ( 2.359 %) | 50.56 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,376,000 | 0.27% | 1,607,581 $ |
Company contact information
Sino Biopharmaceutical Ltd.
Office Tower 1 Harbour Road, Convention Plaza
, Hong Kong
+852 2802 9886
http://www.sinobiopharm.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.33% | 6.46B | |
+54.07% | 809B | |
+38.95% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.21% | 238B | |
-0.45% | 221B | |
+14.58% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- 1177 Stock
- Company Sino Biopharmaceutical Limited